Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11



Status:Completed
Conditions:Psychiatric, Pulmonary
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 75
Updated:2/25/2017
Start Date:December 2003
End Date:August 2005

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Methylphenidate Raclopride PET Test

The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine
release.

The objective of this study is to evaluate PET methodology to study in vivo synaptic
dopamine release.

Inclusion Criteria:

Healthy normals

Exclusion Criteria:

History of head trauma or loss of consciousness. Significant medical history. History of
seizures.
We found this trial at
1
site
New York MDRU
New York, New York 10010
?
mi
from
New York, NY
Click here to add this to my saved trials